Pain management practices are experiencing a new wave of consolidation, with private equity firms acquiring and building multisite platforms. This trend is being driven by the increasing prevalence of chronic pain, the effectiveness of interventional procedural solutions (e.g., nerve blocks, ablations, injections, and device implants), and the shift away from pharmacological treatment (e.g., opioids). Further, outpatient migration is accelerating, as most interventional pain procedures are performed in ambulatory surgery centers (ASCs), driven by advances in minimally invasive techniques and changing reimbursement models.
At the same time, reimbursement pressures and regulatory scrutiny are intensifying. Medicare and commercial payers continue to make downward adjustments to reimbursement rates and are increasingly utilizing "bundled payment" and other innovative programs.
Baker Donelson's Health Care Transactions Team provides comprehensive legal counsel to pain management practices navigating this dynamic environment. Our attorneys advise on strategic transactions, including practice sales, mergers, acquisitions, recapitalizations, and joint ventures with private equity sponsors, health systems, and strategic partners. We also assist with ASC development, licensing, and ownership arrangements.
With deep experience representing pain management groups in strategic transactions and joint ventures, Baker Donelson is committed to protecting physician interests, maximizing practice value, and supporting operational growth.